Ascorbic acid and gastrointestinal cancer.
J Am Coll Nutr
; 14(6): 565-78, 1995 Dec.
Article
en En
| MEDLINE
| ID: mdl-8598417
A literature review was made to critically evaluate the ability of ascorbic acid to modulate the incidence of gastrointestinal cancer. A comparison of preclinical, clinical, and epidemiological studies indicated that evidence for ascorbic acid as an inhibitor of carcinogenesis is stronger with regard to gastric cancer and weaker with regard to esophageal and colon/rectal cancer. Insufficient evidence currently exists regarding the oral cavity and the use of ascorbic acid in precancerous conditions such as polyposis and leukoplakia.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Ácido Ascórbico
/
Anticarcinógenos
/
Neoplasias Gastrointestinales
Límite:
Animals
/
Humans
Idioma:
En
Revista:
J Am Coll Nutr
Año:
1995
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Estados Unidos